Stimulus sensitive gel with radioisotope and methods of making

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Coated – impregnated – or colloidal particulate

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001110, C424S001370

Reexamination Certificate

active

06869588

ABSTRACT:
The present invention is a thermally reversible stimulus-sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an [meth-]acrylamide derivative and a hydrophilic comonomer, wherein the linear random copolymer is in the form of a plurality of linear chains having a plurality of molecular weights greater than or equal to a minimum gelling molecular weight cutoff. Addition of a biodegradable backbone and/or a therapeutic agent imparts further utility. The method of the present invention for making a thermally reversible stimulus-sensitive gelling copolymer radionuclcide carrier has the steps of: (a) mixing a stimulus-sensitive reversible gelling copolymer with an aqueous solvent as a stimulus-sensitive reversible gelling solution; and (b) mixing a radioisotope with said stimulus-sensitive reversible gelling solution as said radioisotope carrier. The gel is enhanced by either combining it with a biodegradable backbone and/or a therapeutic agent in a gelling solution made by mixing the copolymer with an aqueous solvent.

REFERENCES:
patent: 3866050 (1975-02-01), Whitfield
patent: 4190461 (1980-02-01), Hedger
patent: 4510924 (1985-04-01), Gray
patent: 4754745 (1988-07-01), Horowitz
patent: 4763462 (1988-08-01), Johnson, Jr. et al.
patent: H669 (1989-09-01), Fairchild et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5227969 (1993-07-01), Waggener et al.
patent: 5262055 (1993-11-01), Bae et al.
patent: 5322499 (1994-06-01), Liprie
patent: 5424288 (1995-06-01), Order
patent: 5538726 (1996-07-01), Order
patent: 5561698 (1996-10-01), Mick et al.
patent: 5562594 (1996-10-01), Weeks
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5631337 (1997-05-01), Sassi et al.
patent: 5634946 (1997-06-01), Slepian
patent: 5635709 (1997-06-01), Sliski et al.
patent: 5662609 (1997-09-01), Slepian
patent: 5674287 (1997-10-01), Slepian et al.
patent: 5702717 (1997-12-01), Cha et al.
patent: 5749915 (1998-05-01), Slepian
patent: 5749922 (1998-05-01), Slepian et al.
patent: 5762903 (1998-06-01), Park et al.
patent: 5820879 (1998-10-01), Fernandez et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 5942209 (1999-08-01), Leavitt et al.
patent: 5998588 (1999-12-01), Hoffman et al.
patent: 6015541 (2000-01-01), Greff et al.
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6296831 (2001-10-01), Weller et al.
patent: 6352682 (2002-03-01), Leavitt et al.
patent: 6443941 (2002-09-01), Slepian et al.
patent: 6486213 (2002-11-01), Chen et al.
patent: 20020168319 (2002-11-01), Filler et al.
patent: 0730871 (1996-09-01), None
patent: WO 9524430 (1995-09-01), None
patent: WO 9603112 (1996-02-01), None
patent: WO 9855147 (1996-12-01), None
patent: WO 9709068 (1997-03-01), None
patent: WO 9733628 (1998-09-01), None
Chen, G. et al., “Craft Copolymers that Exhibit Temperature-Induced Phase Transitions Over a Wide Range of pH,” pp. 49-52 (1995).
Ning S. et al., “Intratumoral Radioimmunotherapy of a Human Colon Cancer Xengraft Using a Sustained-Release Gel,” pp. 179-189 (1996).
Order, SE. et al., “Preliminary Experience of Infusional Brachytherapy Using Colloidal32P,” pp. 347-351 (1996).
“Copper Chelates as Probes of Biological Systems: Stable Copper Complexes with a Macrocyclic Bifunctional Chelating Agent”, by MK Moi et al., p. 249-253. 1985.
“Environmentally Sensitive Polymers and Hydrogels”, by AS Hoffman, p. 42-46. 1991.
“Gelation of Globular Proteins: Effect of pH and Ionic Strength on the Critical Concentration for Gel Formation. A Simple model and its application toβ-Lactoglobulin Heat-Induced Gelation.”, p. 287-291. 1992.
“Hawley's Condensed Chemical Dictionary”,by RJ Lewis, Sr., p. 28, 124-125, 256, 785. 1993.
“Hydrogels in Medicine and Pharmacy”, vol. II Polymers, by NA Peppas, p. 115-160, 1987.
“Intelligent Gels”, by Y Osada et al., p. 82-87. 1993.
“Intratumoral Radiommunotherapy of a Human Colon Cancer Xenograft Using a Sustained-Release Gel”, by Ning et al., p. 179-189. 1996.
“Lower Critical Solution Temperatures of Aqueous Copolymers of N-Isopropylacrylamide and Other N-Substituted Acrylamides”, by JH Priest et al., p. 255-264. 1987.
“Phase Transitions in Cross-Linked Gels of Natural Polymers”, by T Amiya et al., p. 1162-1164. 1987.
“Polymer Communications”, by Q Yan et al., p. 887-889. 1995.
“Synthesis Characterization, and 1/T1NMRD Profiles of Gadolinium(III)Complexes of Monoamide Derivatives of DOTA-Like Ligands.” By. S Aime et al., p. 2422-2428. 1991.
“Synthesis and Characterization of the Gadolinium(3+)Complex of DOTA-Propylamide: A Model DOTA-Protein Conjugate.” By. AD Sherry et al., p. 620-622. 1989.
“Temperature Dependence of Swelling of Crosslinked Poly(N, N'-Alkyl Substituted Acrylamides)in Water.” by, YH Bae et al., p. 923-936. 1990.
“Thermosensitive Polymers for Drug Delivery”, by A Gutowska et al., p. 115-116. 1996.
Vernon, Brent et al., “Thermally Reversible Polymer Gels for Biohybrid Artificial Pancreas,” Macromol. Symp., vol. 109, pp. 155-167 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stimulus sensitive gel with radioisotope and methods of making does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stimulus sensitive gel with radioisotope and methods of making, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulus sensitive gel with radioisotope and methods of making will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3418127

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.